Immatics (IMTX) Net Debt Issuances and Repayments (2019 - 2022)
Immatics (IMTX) reported Net Debt Issuances and Repayments of $128.2 billion for Q1 2022, up 629.1% on a YoY basis from $17.6 billion in Q1 2021, and up 629.1% sequentially from $17.6 billion in Q1 2021.
Immatics (IMTX) Net Debt Issuances and Repayments (2019 - 2022) Analysis & Trends
Immatics (IMTX) has 4 years of Net Debt Issuances and Repayments data on file, last reported at $128.2 billion in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Immatics | 1.06 Bn | 515.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 128.23 Bn |
| Mar 31, 2022 | 128.23 Bn |
| Mar 31, 2021 | 17.59 Bn |
| Mar 31, 2021 | 17.59 Bn |
| Sep 30, 2020 | 174.92 Bn |
| Sep 30, 2020 | 174.92 Bn |
| Jun 30, 2020 | -53.66 Bn |
| Jun 30, 2020 | -53.66 Bn |
| Mar 31, 2020 | 34.54 Bn |
| Mar 31, 2020 | 34.54 Bn |
| Sep 30, 2019 | 50.90 Bn |
| Sep 30, 2019 | 50.90 Bn |